| Size | 30mg |
|---|
Retatrutide (30mg)
$145.00
A next-generation triple-receptor agonist peptide targeting GLP-1, GIP, and glucagon receptors. Supplied as a lyophilized research compound at 30mg per vial.
For Research Use Only. Not intended for human consumption. These products are not approved by the FDA and are not intended to diagnose, treat, cure, or prevent any disease or medical condition.
Reviews
There are no reviews yet.